Literature DB >> 10509006

Dizygotic twin sisters with myelokathexis: mechanism of its neutropenia.

S Taniuchi1, A Yamamoto, T Fujiwara, M Hasui, S Tsuji, Y Kobayashi.   

Abstract

Dizygotic twin sisters were first found to have neutropenia at 1 year of age when evaluated for recurrent pulmonary infections. Since then they have remained neutropenic (0.05 approximately 0.5 x 10(9)/l). Despite of their neutropenia, myeloid hyperplasia was evident on a marrow smear examination, and a number of cells were hypersegmented with fine interlobular bridging with chromatin strands and cytoplasmic vacuolation. Electron microscopy showed apoptotic cells with condensed nuclei and apoptotic bodies in the cytoplasm. Although life span, hydrogen peroxide production, phagocytosis, spreading, and chemotaxis of peripheral neutrophils were normal, the survival of bone marrow neutrophils in both infants was markedly decreased when compared with that of normal bone marrow neutrophils. During the bone marrow culture apoptotic neutrophils were observed at an earlier stage in both patients than in normal controls, biochemically and morphologically. Morphology of bone marrow neutrophils in both patients resembled that of cultured control bone marrow neutrophils. Peripheral neutropenia and appearance of characteristic neutrophils in the bone marrow in myelokathexis are considered to be an expression of apoptosis of bone marrow neutrophils. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10509006     DOI: 10.1002/(sici)1096-8652(199910)62:2<106::aid-ajh8>3.0.co;2-d

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  9 in total

1.  WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.

Authors:  Toshinao Kawai; Uimook Choi; Lanise Cardwell; Suk See DeRavin; Nora Naumann; Narda L Whiting-Theobald; Gilda F Linton; Jaehyun Moon; Philip M Murphy; Harry L Malech
Journal:  Blood       Date:  2006-08-31       Impact factor: 22.113

Review 2.  Genetics on a WHIM.

Authors:  Omar Al Ustwani; Razelle Kurzrock; Meir Wetzler
Journal:  Br J Haematol       Date:  2013-09-20       Impact factor: 6.998

Review 3.  Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.

Authors:  Philip M Murphy; Lauren Heusinkveld
Journal:  Cytokine       Date:  2018-02-15       Impact factor: 3.861

Review 4.  WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure.

Authors:  Lauren E Heusinkveld; Shamik Majumdar; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  J Clin Immunol       Date:  2019-07-16       Impact factor: 8.317

Review 5.  Neutrophil homeostasis: a new role for stromal cell-derived factor-1.

Authors:  Daniel C Link
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 6.  WHIM syndrome: congenital immune deficiency disease.

Authors:  Toshinao Kawai; Harry L Malech
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

7.  Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency.

Authors:  Lauren E Heusinkveld; Erin Yim; Alexander Yang; Ari B Azani; Qian Liu; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  Expert Opin Orphan Drugs       Date:  2017-09-25       Impact factor: 0.694

Review 8.  WHIM syndrome: a defect in CXCR4 signaling.

Authors:  George A Diaz; A Virginia Gulino
Journal:  Curr Allergy Asthma Rep       Date:  2005-09       Impact factor: 4.919

9.  Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry.

Authors:  Sarah Beaussant Cohen; Odile Fenneteau; Emmanuel Plouvier; Pierre-Simon Rohrlich; Gerard Daltroff; Isabelle Plantier; Alain Dupuy; Delphine Kerob; Blandine Beaupain; Pierre Bordigoni; Fanny Fouyssac; Anne-Lise Delezoide; Gilles Devouassoux; Jean François Nicolas; Philippe Bensaid; Yves Bertrand; Karl Balabanian; Christine Bellanne Chantelot; Françoise Bachelerie; Jean Donadieu
Journal:  Orphanet J Rare Dis       Date:  2012-09-25       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.